Download App

Log in to access Online Inquiry
Company Overview More
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

NGENF NERVGEN PHARMA CORP
1.690-0.020-1.17%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
157.25% 12.83M 202.38% 16.93M 202.38% 16.93M 7.76% 8.25M
-Cash and cash equivalents
157.25% 12.83M 202.38% 16.93M 202.38% 16.93M 7.76% 8.25M
Receivables
114.52% 69.87K 2.25% 64K 2.25% 64K 659.12% 41.97K
-Accounts receivable
114.52% 69.87K 2.25% 64K 2.25% 64K 659.12% 41.97K
Prepaid assets
-36.13% 527.34K -20.93% 427.58K -20.93% 427.58K -71.5% 599.83K
Total current assets
129.7% 13.43M 180.89% 17.42M 180.89% 17.42M -8.96% 8.89M
Non current assets
Net PPE
354.97% 7.13K 34.82% 2.69K 34.82% 2.69K 42.88% 3.46K
Goodwill and other intangible assets
0.19% 462.72K 0.37% 473.15K 0.37% 473.15K 0.55% 483.59K
-Other intangible assets
0.19% 462.72K 0.37% 473.15K 0.37% 473.15K 0.55% 483.59K
Total non current assets
1.39% 469.85K 0.52% 475.84K 0.52% 475.84K 0.76% 487.05K
Total assets
120.27% 13.9M 168.1% 17.9M 168.1% 17.9M -8.5% 9.38M
Liabilities
Current liabilities
Payables
-3.71% 957.44K 87.04% 626.61K 87.04% 626.61K 310.59% 894.77K
-accounts payable
8.98% 823.86K 105.25% 352.55K 105.25% 352.55K 1274.92% 616.93K
-Due to related parties current
-43.95% 133.58K 67.88% 274.06K 67.88% 274.06K 60.55% 277.84K
Current accrued expenses
-1.39% 161.95K 7.48% 451.47K 7.48% 451.47K 80.11% 190.18K
Current liabilities
-3.38% 1.12M 42.78% 1.08M 42.78% 1.08M 235.36% 1.08M
Non current liabilities
Total non current liabilities
-- 0 -- 0 -- 0 -- 0
Total liabilities
-3.38% 1.12M 42.78% 1.08M 42.78% 1.08M 235.36% 1.08M
Shareholders'equity
Share capital
77.22% 42.55M 84.79% 42.4M 84.79% 42.4M 36.53% 31.22M
-common stock
77.22% 42.55M 84.79% 42.4M 84.79% 42.4M 36.53% 31.22M
Retained earnings
-62.87% -40.02M -57.01% -35.05M -57.01% -35.05M -74.09% -30.9M
Gains losses not affecting retained earnings
79.39% 10.24M 78.72% 9.46M 78.72% 9.46M 65.84% 7.97M
Total stockholders'equity
148.09% 12.78M 184.08% 16.82M 184.08% 16.82M -16.45% 8.29M
Total equity
148.09% 12.78M 184.08% 16.82M 184.08% 16.82M -16.45% 8.29M
Currency Unit
CADCADCADCAD
Audit Opinions
--Unqualified Opinion----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%